Lifetime Obesity Exposure Underestimated in Cancer Care[
A study of over 79,000 cancer patients in England reveals that obesity is significantly more prevalent than previously thought when considering lifetime history rather than just BMI at the start of treatment. Researchers found that over half of the cohort had experienced obesity at some point, suggesting that current clinical assessments may overlook long-term health risks.
Why it matters
Understanding the full history of obesity exposure is crucial for improving cancer prognosis and developing more accurate risk assessment models in oncology.
Lifetime obesity affected more than half of patients receiving systemic anticancer therapy in England, according to a large real-world analysis that found obesity measured at treatment initiation substantially underestimated previous exposure across a range of cancer types.
The article reports on scientific research findings without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in